Cargando…

Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy

BACKGROUND: The successful ex vivo expansion of T-cells in great numbers is the cornerstone of adoptive cell therapy. We aimed to achieve the most optimal T-cell expansion condition by comparing the expansion of T-cells at various seeding densities, IL-2 concentrations, and bead-to-cell ratios. we f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaffari, Sasan, Torabi-Rahvar, Monireh, Aghayan, Sajjad, Jabbarpour, Zahra, Moradzadeh, Kobra, Omidkhoda, Azadeh, Ahmadbeigi, Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254233/
https://www.ncbi.nlm.nih.gov/pubmed/34217218
http://dx.doi.org/10.1186/s12865-021-00435-7
_version_ 1783717687256416256
author Ghaffari, Sasan
Torabi-Rahvar, Monireh
Aghayan, Sajjad
Jabbarpour, Zahra
Moradzadeh, Kobra
Omidkhoda, Azadeh
Ahmadbeigi, Naser
author_facet Ghaffari, Sasan
Torabi-Rahvar, Monireh
Aghayan, Sajjad
Jabbarpour, Zahra
Moradzadeh, Kobra
Omidkhoda, Azadeh
Ahmadbeigi, Naser
author_sort Ghaffari, Sasan
collection PubMed
description BACKGROUND: The successful ex vivo expansion of T-cells in great numbers is the cornerstone of adoptive cell therapy. We aimed to achieve the most optimal T-cell expansion condition by comparing the expansion of T-cells at various seeding densities, IL-2 concentrations, and bead-to-cell ratios. we first expanded the peripheral blood mononuclear cells (PBMCs) of a healthy donor at a range of 20 to 500 IU/mL IL-2 concentrations, 125 × 10(3) to 1.5 × 10(6) cell/mL, and 1:10 to 10:1 B:C (Bead-to-cell) ratios and compared the results. We then expanded the PBMC of three healthy donors using the optimized conditions and examined the growth kinetics. On day 28, CD3, CD4, and CD8 expression of the cell populations were analyzed by flow cytometry. RESULTS: T-cells of the first donor showed greater expansion results in IL-2 concentrations higher than 50 IU/mL compared to 20 IU/mL (P = 0.02). A seeding density of 250 × 10(3) cell/mL was superior to higher or lower densities in expanding T-cells (P = 0.025). Also, we witnessed a direct correlation between the B:C ratio and T-cell expansion, in which, in 5:1 and 10:1 B:C ratios T-cell significantly expanded more than lower B:C ratios. The results of PBMC expansions of three healthy donors were similar in growth kinetics. In the optimized condition, 96–98% of the lymphocyte population expressed CD3. While the majority of these cells expressed CD8, the mean expression of CD4 in the donors was 19.3, 16.5, and 20.4%. CONCLUSIONS: Our methodology demonstrates an optimized culture condition for the production of large quantities of polyclonal T-cells, which could be useful for future clinical and research studies.
format Online
Article
Text
id pubmed-8254233
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82542332021-07-06 Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy Ghaffari, Sasan Torabi-Rahvar, Monireh Aghayan, Sajjad Jabbarpour, Zahra Moradzadeh, Kobra Omidkhoda, Azadeh Ahmadbeigi, Naser BMC Immunol Research BACKGROUND: The successful ex vivo expansion of T-cells in great numbers is the cornerstone of adoptive cell therapy. We aimed to achieve the most optimal T-cell expansion condition by comparing the expansion of T-cells at various seeding densities, IL-2 concentrations, and bead-to-cell ratios. we first expanded the peripheral blood mononuclear cells (PBMCs) of a healthy donor at a range of 20 to 500 IU/mL IL-2 concentrations, 125 × 10(3) to 1.5 × 10(6) cell/mL, and 1:10 to 10:1 B:C (Bead-to-cell) ratios and compared the results. We then expanded the PBMC of three healthy donors using the optimized conditions and examined the growth kinetics. On day 28, CD3, CD4, and CD8 expression of the cell populations were analyzed by flow cytometry. RESULTS: T-cells of the first donor showed greater expansion results in IL-2 concentrations higher than 50 IU/mL compared to 20 IU/mL (P = 0.02). A seeding density of 250 × 10(3) cell/mL was superior to higher or lower densities in expanding T-cells (P = 0.025). Also, we witnessed a direct correlation between the B:C ratio and T-cell expansion, in which, in 5:1 and 10:1 B:C ratios T-cell significantly expanded more than lower B:C ratios. The results of PBMC expansions of three healthy donors were similar in growth kinetics. In the optimized condition, 96–98% of the lymphocyte population expressed CD3. While the majority of these cells expressed CD8, the mean expression of CD4 in the donors was 19.3, 16.5, and 20.4%. CONCLUSIONS: Our methodology demonstrates an optimized culture condition for the production of large quantities of polyclonal T-cells, which could be useful for future clinical and research studies. BioMed Central 2021-07-03 /pmc/articles/PMC8254233/ /pubmed/34217218 http://dx.doi.org/10.1186/s12865-021-00435-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ghaffari, Sasan
Torabi-Rahvar, Monireh
Aghayan, Sajjad
Jabbarpour, Zahra
Moradzadeh, Kobra
Omidkhoda, Azadeh
Ahmadbeigi, Naser
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
title Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
title_full Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
title_fullStr Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
title_full_unstemmed Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
title_short Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
title_sort optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of t-cell expansion for adoptive immunotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254233/
https://www.ncbi.nlm.nih.gov/pubmed/34217218
http://dx.doi.org/10.1186/s12865-021-00435-7
work_keys_str_mv AT ghaffarisasan optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy
AT torabirahvarmonireh optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy
AT aghayansajjad optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy
AT jabbarpourzahra optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy
AT moradzadehkobra optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy
AT omidkhodaazadeh optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy
AT ahmadbeiginaser optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy